Inventors:
- Cambridge MA, US
Cassandra CELATKA - Hull MA, US
Seng CHENG - Natick MA, US
Mary A. CROMWELL - Groton MA, US
Andrew GOOD - Wallingford CT, US
Bradford HIRTH - Framingham MA, US
Katherine JANCSICS - Wilmington MA, US
John P. LEONARD - Manchester NH, US
Lingyun LI - Waltham MA, US
James LILLIE - Wellesley MA, US
Hanlan LIU - Lexington MA, US
Elina MAKINO - Winchester MA, US
John MARSHALL - Hopedale MA, US
Paul MASON - Natick MA, US
Markus METZ - Waltham MA, US
Fazeela MORSHED - Waltham MA, US
Thomas O'SHEA - Wellesley MA, US
Ronald SCHEULE - Hopkinton MA, US
Renato SKERLJ - West Newton MA, US
Bing WANG - Newton MA, US
Yibin XIANG - Dracut MA, US
Zhong ZHAO - Wayland MA, US
Assignee:
GENZYME CORPORATION - Cambridge MA
International Classification:
C07D 487/08
A61K 31/439
A61K 31/454
A61K 38/47
C07D 453/02
C07D 453/00
A61K 31/46
A61K 31/506
A61K 31/551
C07D 455/02
Abstract:
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.